Sound Investments. Solid Relationships.

Our Services

We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.

Investment Banking

Equity Research

Capital Markets

Merchant Capital

Wealth Management

Prime Brokerage

Recent
Transactions

Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
SeaStar Medical has redefined how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs through novel solutions and services.
Up to $9.8 Million
PIPE
// Sole Placement Agent
March 2023
maxim-column-blue
Screen Shot 2023-03-16 at 4.20.45 PM
$8.0 Million
Registered Direct Offering
// Sole Placement Agent
March 2023
maxim-column-blue
download
Up to $130 Million
PIPE
// Financial Advisor
March 2023
maxim-column-blue
performance shipping
$12.5 Million
Registered Direct
// Sole Placement Agent
March 2023
maxim-column-blue
[www.maximgrp.com][679]logo-contrafect
$10.0 Million
Registered Direct Offering
// Sole Placement Agent
February 2023
maxim-column-blue
Screen Shot 2023-03-08 at 3.14.46 PM
$5.0 Million
Registered Direct
// Sole Placement Agent
February 2023
maxim-column-blue
aprea_logo@2x
$5.5 Million
CMPO
// Sole Book-Running Manager
February 2023
maxim-column-blue
cb6fa347-14a8-4cec-af45-3bce7007648d
$7.0 Million
Follow-On Offering
// Co-Placement Agent
February 2023
maxim-column-blue
amv-black-on-white-01-1280x-q95
$13.0 Million
Follow-On Offering
// Sole Placement Agent
February 2023
maxim-column-blue
Screenshot-2023-02-14-145537-e1677004657660-300x181
$60.0 Million
Initial Public Offering
// Sole Book-Running Manager
February 2023
maxim-column-blue
top-ships
$13.6 Million
Registered Direct Offering
// Sole Placement Agent
February 2023
maxim-column-blue

Upcoming Events

Maxim Group events are hosted on our digital platform, M-Vest

Electric Vehicle & Auto Tech Virtual Conference
Electric Vehicle & Auto Tech Virtual Conference
March 30, 2023 | 8:30 AM ET

Merchant Capital

Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.

Scroll to Top